Statistics for XBiotech (id:8346 XBIT)
Valuation metrics
Market cap
208.20M
Enterprise value
28.68M
Trailing P/E (ttm)
-8.43
Forward P/E
52.54
PEG ratio
52.54
Price/Sales (ttm)
Price/Book (mrq)
1.08
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.71
Overview
Shares outstanding
30.48M
Float
19.84M
Shares short
848.30K
% Held by insiders
0.35%
% Held by institutions
0.16%
Average volume (10 days)
47.60K
Average volume (90 days)
Price summary
52-Week low
3.60
52-Week high
9.96
52-Week change
45.10%
Beta
1.41
50-Day moving average
7.23
200-Day moving average
7.06
Dividends and splits
Forward annual dividend rate
10.00
Forward annual dividend yield
1.46
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
July 23th, 2021
Ex-dividend date
July 15th, 2021
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-12.03%
Return on equity
-15.75%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-40,570,000.00
Net income to common (ttm)
-32,658,000.00
Diluted EPS (ttm)
-1.08
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
183.12M
Total cash per share (mrq)
6.01
Total debt (mrq)
10.00M
Total Debt/Equity (mrq)
5.20
Current ratio (mrq)
1.16K%
Book value per share (mrq)
6.31
Cash flow
Cash flow statement
-27,856,000.00
Levered free cash flow (LFCF)
-22,160,624.00